enGenes to Present ‘Reprogramming E. coli’ breakthrough to Bioprocessing Network Australia

Vienna, Austria: – Bioprocessing solutions expert enGenes Biotech has been invited to make its first-ever appearance at the Bioprocessing Network conference in Melbourne, Australia.

enGenes CEO and co-founder, Dr. Jürgen Mairhofer will be one of the keynote speakers at the conference, presenting the company’s remarkable progress towards the first continuous and sustainable production of proteins in E. coli as part of the ECOnti Project.

Continuous production prototype

ECOnti, which has unveiled a first working prototype of its new platform, depends on enGenes proprietary technologies e^Xpress^® for high-yield Escherichia coli recombinant expression and e^Xcite®, a cutting-edge technology for continuous manufacturing of biomolecules in E. coli, providing high yield and productivity from a very small footprint.

To read the whole article, click here: https://www.pharmaceutical-networking.com/engenes-to-present-reprogramming-e-coli-breakthrough-to-bioprocessing-network-australia/